GENTIBIO Trademark

Trademark Overview

On Tuesday, August 11, 2020, a trademark application was filed for GENTIBIO with the United States Patent and Trademark Office. The USPTO has given the GENTIBIO trademark a serial number of 90107117. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, September 19, 2023. This trademark is owned by GentiBio Inc.. The GENTIBIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders
gentibio

General Information

Serial Number90107117
Word MarkGENTIBIO
Filing DateTuesday, August 11, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, September 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 19, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGentiBio Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameGentiBio Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02111

Trademark Events

Event DateEvent Description
Wednesday, September 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 19, 2023SOU EXTENSION 5 GRANTED
Tuesday, September 12, 2023SOU EXTENSION 5 FILED
Tuesday, September 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 14, 2023SOU EXTENSION 4 GRANTED
Tuesday, March 14, 2023SOU EXTENSION 4 FILED
Tuesday, March 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 14, 2022SOU EXTENSION 3 GRANTED
Wednesday, September 14, 2022SOU EXTENSION 3 FILED
Wednesday, September 14, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 16, 2022SOU EXTENSION 2 GRANTED
Wednesday, March 16, 2022SOU EXTENSION 2 FILED
Wednesday, March 16, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 15, 2021SOU EXTENSION 1 GRANTED
Wednesday, September 15, 2021SOU EXTENSION 1 FILED
Wednesday, September 15, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 26, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 26, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, January 26, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 26, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 26, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 4, 2020ASSIGNED TO EXAMINER
Monday, September 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 14, 2020NEW APPLICATION ENTERED

Related Keywords

gentibio disorders diseases alloimmune allergic autoinflammatory preparations autoimmune pharmaceutical treatment